Welcome to our dedicated page for Medifast news (Ticker: MED), a resource for investors and traders seeking the latest updates and insights on Medifast stock.
Medifast, Inc. (NYSE: MED) generates a steady flow of news centered on its health and wellness programs, metabolic health strategy, and financial performance. As the company behind the OPTAVIA® lifestyle system and the Metabolic Synchronization™ framework, Medifast regularly issues updates that highlight how it is addressing obesity, lifestyle change, and the broader challenge of metabolic dysfunction.
Readers of this MED news page can expect coverage of quarterly and annual financial results, including trends in revenue, the number of independent active earning OPTAVIA coaches, and revenue per active earning coach. These releases often include commentary from leadership on business transformation, strategic priorities, and the company’s focus on metabolic health and long-term growth.
Medifast also publishes scientific and clinical news, such as research presented at conferences like ObesityWeek. These updates describe studies on topics including lean mass preservation on the Optimal Weight 5 & 1 Plan®, the long-term effects of anti-obesity medications, and links between sleep quality and metabolic outcomes. Such items illustrate how the company’s Scientific & Clinical Affairs team and Scientific Advisory Board contribute to evidence-based program development.
In addition, investors and observers will find corporate and strategic announcements, including the introduction of Metabolic Synchronization™, shifts in positioning from weight loss to metabolic health, and leadership or governance changes documented in press releases and related SEC filings. The company also highlights brand and educational initiatives, such as the “Health by Design” docuseries that explores cultural and environmental factors influencing metabolic health and longevity.
This news page is a central resource for following Medifast’s evolving approach to metabolic health, its OPTAVIA coach network, research milestones, and key corporate developments. For those tracking MED, it offers a consolidated view of how the company communicates its strategy, science, and financial trajectory over time.
Medifast, Inc. (NYSE: MED) announced a $1.13 quarterly cash dividend, payable on February 5, 2021, to stockholders of record by December 22, 2020. This marks the 20th consecutive quarterly dividend for the company, which has disbursed $139 million in cash dividends since December 2015. The Board plans to continue its dividend program quarterly, with future dividend declarations under its discretion. CEO Dan Chard emphasized strong growth amidst economic challenges, showcasing commitment to delivering shareholder value and sustainable growth strategies.
Medifast (NYSE: MED) reported a strong third quarter for 2020, with revenue rising 42.8% to $271.5 million compared to $190.1 million from the prior year. The net income surged 116.7% to $34.5 million, yielding earnings per diluted share of $2.91, up 120.5%. Active earning OPTAVIA Coaches grew 30.7% to a record 42,100. Despite increased SG&A expenses, the company's balance sheet remains strong with $169.9 million in cash and no debt. Medifast declared a quarterly cash dividend of $1.13 per share, demonstrating commitment to shareholder returns.
Summary not available.
Medifast, Inc (NYSE: MED) will announce its third-quarter financial results for the period ending September 30, 2020, on November 2, 2020, following the market close. A conference call will be held at 4:30 p.m. ET that day, featuring CEO Dan Chard and CFO Jim Maloney. The call will be accessible via the company’s investor relations website and will be archived for later listening until November 16, 2020. Medifast, known for its OPTAVIA® brand, focuses on health and wellness with a community of independent coaches supporting clients in developing healthy habits.
Medifast (NYSE: MED) recently hosted its second annual Healthy Habits For All Week, aimed at improving health education in underserved communities. The event took place from September 21-27, 2020, with volunteers assembling 'mindfulness bags' in collaboration with the Living Classrooms Foundation. To date, Medifast has connected children with up to 6 million nutritious meals and contributed $100,000 to No Kid Hungry Campaign. The initiative reflects Medifast's commitment to promoting sustainable health habits, even amid pandemic challenges.
Medifast (NYSE: MED) has appointed Lauren Walker as Executive Vice President of Supply Chain Operations, effective Sept. 21, 2020. Walker, previously Chief Supply Chain Officer at Young Living Essential Oils, will oversee Medifast's global supply chain organization. CEO Dan Chard expressed confidence in her ability to drive operational excellence. Walker's extensive experience includes roles at Amway, Procter & Gamble, and Johnson & Johnson. This leadership change is expected to enhance Medifast's operational capabilities and support its growth strategy.
Medifast (NYSE: MED) has declared a quarterly cash dividend of $1.13 per share, slated for payment on November 6, 2020, to stockholders on record as of September 22, 2020. The company aims to maintain its quarterly dividend program, subject to Board discretion. Medifast continues to grow through its wellness community, OPTAVIA®, and aims for strategic expansion, particularly in the Asia-Pacific region. This dividend declaration reflects the company's ongoing commitment to shareholder returns.
Medifast (NYSE: MED) reported a strong second quarter for 2020, with revenue increasing by 17.6% to $220.0 million. The company experienced a 19.3% rise in active earning OPTAVIA Coaches, totaling 36,500. Net income rose 2.6% to $21.9 million, with earnings per diluted share of $1.86, marking a 6.3% increase. Despite higher promotional costs impacting gross profit margins, which fell to 72.4%, Medifast's cash position improved to $145.4 million. A quarterly cash dividend of $1.13 per share was declared, emphasizing the company's commitment to returning value to shareholders.
Medifast (NYSE: MED) hosted its OPTAVIA Together Live event from July 24-26, 2020, attracting over 50,000 global registrants amidst the pandemic. The event featured educational sessions and panel discussions, achieving 140,000 views on Facebook. CEO Dan Chard emphasized the community's resilience and the company's strategic focus on an integrated coach model, which has nearly tripled revenue since 2016. Medifast will announce its Q2 2020 financial results on August 5, 2020, showcasing its ongoing growth in the health and wellness sector.
Medifast, Inc. (NYSE: MED) plans to release its financial results for Q2 2020, ending June 30, on August 5, 2020, after market close. The announcement will be followed by a conference call at 4:30 p.m. ET to discuss the results, featuring CEO Dan Chard and CFO Jim Maloney. The call can be accessed live on Medifast's investor relations website, with an archived version available until August 19, 2020. The results will shed light on the company’s performance and growth strategies impacted by its expanding health and wellness community, OPTAVIA®.